Sunil Dhawan is a Dermatology physician affiliated with Electronics for Imaging. OpenAlex indexes 59 publications with 1,504 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2557 Mowry Ave
Ste 34
Fremont, CA 94538
Telephone
510-797-4111Registry record last updated 1 Oct 2010.
Clinical trials
- Using a Novel Skin Tag Removal Device
Sponsor: UK Innovations GP LTD
- Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea
Sponsor: Hovione Scientia Limited
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202518 payments
- LEO Pharma Inc.Program year202521 payments
- PFIZER INC.Program year202513 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
87.4%Porphyrin Precursor86.4%Aminolevulinic acid hcl100%Part B, office-administered≥68 patientsCalcineurin inhibitor0.4%Tacrolimus100%Part D≥39 patients+ 4 more classes in this area
Dermatology
3.4%Corticosteroid2.2%Triamcinolone Acetonide52%Triamcinolone acetonide48%Part D + Part B≥122 patientsOther antifungals for topical use0.6%Selenium Sulfide63%Ciclopirox37%Part D≥30 patients+ 4 more classes in this area
Sensory organs
3.2%Corticosteroid3.2%Hydrocortisone48%Betamethasone Dipropionate35%Desonide10%Betamethasone Diprop Augmented4%Clobetasol Propionate3%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”